Healthcare

The rise of GLP-1s has fractured the patient advocacy landscape, creating new risks and opportunities for pharma. This case study analyzes the key advocacy archetypes shaping GLP-1 access policy and explains why dynamic, AI-driven intelligence is now essential.

Case study Policy-Insider.AI powers RPP’s Health Policy Leaders analysis We are excited to share that Policy-Insider.AI has been utilized by RPP for its pivotal analysis of the impact of policymakers in European health policy, now published at Health Policy Leaders (HPL). This application underscores our platform’s capacity to support significant analyses and encourage profound discussions […]

Webapp Release Two powerful new sources on Policy-Insider.AI We’re back with even more exciting news from Policy-Insider.AI. Our mission has always been to provide you with the most comprehensive policy insights. Thus, we’re taking it up a notch with the addition of two new data sources: Bundesnetzagentur and the European Medicines Agency. Source 01 Bundesnetzagentur: […]